![]() |
|
|
Vol. 284, Issue 1, 317-322, 1998
Department of Psychiatry, The University of Chicago, Chicago,
Illinois
This study examined the role played by metabotropic glutamate receptors
in the nucleus accumbens in dopamine agonist-induced locomotion. Rats
received microinjections into this nucleus of the selective
metabotropic glutamate receptor antagonist,
(RS)-
-methyl-4-carboxyphenylglycine, alone or with
amphetamine and their locomotor activity was subsequently measured for
2 hr. None of the doses of
(RS)-
-methyl-4-carboxyphenylglycine tested (0.025, 0.25, 2.5, or 25 nmol/0.5 µl/side) when administered alone produced
effects on locomotion that differed significantly from those observed
after saline. However, when co-injected with amphetamine (6.8 nmol
[2.5 µg]/side) into the nucleus accumbens, a moderately high dose
of (RS)-
-methyl-4-carboxyphenylglycine (25 nmol/side)
completely blocked, whereas a lower dose (0.25 nmol/side) potentiated
the locomotor effects of amphetamine.
(RS)-
-Methyl-4-carboxyphenylglycine (25 nmol/side)
also blocked the locomotor-activating effects of apomorphine (32.9 nmol
[10 µg]/side), when co-injected with this direct dopamine receptor
agonist into the nucleus accumbens. These results suggest that
metabotropic glutamate receptors in the nucleus accumbens contribute to
amphetamine-induced locomotion and that this contribution may be
mediated, at least in part, by metabotropic glutamate receptors
expressed by intrinsic nucleus accumbens cells located postsynaptic to
dopamine neuron terminals.
This article has been cited by other articles:
![]() |
C. J. Swanson, D. A. Baker, D. Carson, P. F. Worley, and P. W. Kalivas Repeated Cocaine Administration Attenuates Group I Metabotropic Glutamate Receptor-Mediated Glutamate Release and Behavioral Activation: A Potential Role for Homer J. Neurosci., November 15, 2001; 21(22): 9043 - 9052. [Abstract] [Full Text] [PDF] |
||||